Nonetheless, our study offers meaningful insight into the potential role of TNF-α inhibition in COVID-19 and underscores the urgent need for large, well-designed randomised trials to further clarify its therapeutic value and clinical implications. The gene discussed is TNF; the disease is COVID-19.